Develops and markets chelated products for possible use in combination with existing therapies for cancer and atherosclerosis. Includes product pipeline, technology and investor details. Sunnyvale, California. (Nasdaq: PCYC)
Pharmacyclics, Inc.
Pharmacyclics Novel small-molecule drugs for cancer and other serious diseases
2024-08-23
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - Pharmacyclics, Inc.. Develops and markets chelated products for possible use in combination with existing therapies for cancer and atherosclerosis.